Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 4Cancer Pain 4Neoplasms 3Urinary Bladder Neoplasms 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Signs and Symptoms 1Postoperative Complications 1Pathologic Processes 1Pain, Postoperative 1Pain Related to Cancer 1Neurologic Manifestations 1Neuralgia 1Head and Neck Neoplasms 1Chronic Pain 1Breakthrough Pain 1

Interventions

Fentanyl 5Morphine 2Urinary Catheterization 1Ultracet 1Patient Positioning 1Methadone 1Gastrostomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breakthrough Pain × Methadone × Clear all
NCT00125294 2017-09-25

Sublingual Methadone for the Management of Cancer Breakthrough Pain

AHS Cancer Control Alberta

Phase 1 Completed
10 enrolled

Cancer Pain, Neoplasms, Pain, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡